Can hypertonic saline inhalation influence preformed chemokine and mediator release in induced sputum of chronic obstructive pulmonary disease patients? Comparison with isotonic saline

Clinical and Experimental Allergy

Volumn 37, Issue 12, 2007, Pages 1819-1826

  Cianchetti, S ^a   Bacci, E ^a   Bartoli, M L ^a   Ruocco, L ^b   Pavia, T ^b   Dente, F L ^a   Di Franco, A ^a   Vagaggini, B ^a   Paggiaro, P ^a  

^a Pneumology Section   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Chemokines; COPD; ECP; Elastase; Induced sputum

Indexed keywords

CHEMOKINE; EOSINOPHIL CATIONIC PROTEIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE;

AGED; ANALYTIC METHOD; ARTICLE; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HYPEROSMOLARITY; LEUKOCYTE DIFFERENTIAL COUNT; MACROPHAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL; SPUTUM; SPUTUM ANALYSIS;

AGED; CHEMOKINES; FEMALE; HUMANS; INHALATION; ISOTONIC SOLUTIONS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SALINE SOLUTION, HYPERTONIC; SOLUBILITY; SPUTUM;

EID: 36349005804     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02850.x     Document Type: Article

References (44)

1. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003 97 : 863 71.
2. Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002 57 : 667 71.
3. Kelly MM, Leigh R, Horsewood P, Gleich GJ, Cox G, Hargreave FE. Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol 2000 105 : 1162 8.
4. Moloney ED, Griffin S, Burke CM, Poulter LW, O'Sullivan S. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med 2003 97 : 928 32.
5. Owen JS, Baker PRS, O'Flaherty JT et al. Stress-induced platelet-activating factor synthesis in human neutrophils. Biochimica Biophysica Acta 2005 1733 : 120 9.
6. Rizoli SB, Rotstein OD, Parodo J, Phillips MJ, Kapus A. Hypertonic inhibition of exocytosis in neutrophils: central role for osmotic actin skeleton remodeling. Am J Physiol Cell Physiol 2000 279 : C619 33.
7. Junger WG, Hoyt DB, Davis RE et al. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J Clin Invest 1998 101 : 2768 79.
8. Angle N, Cabello-Passini R, Hoyt DB et al. Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000 14 : 503 8.
9. Bacci E, Cianchetti S, Paggiaro PL et al. Comparison between hypertonic and isotonic saline-induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy 1996 26 : 1395 400.
10. Cataldo D, Foidart JM, Lau L, Bartsch P, Djukanovic R, Louis R. Comparison between isotonic and hypertonic saline solution inhalation in patients with asthma. Chest 2001 120 : 1815 21.
11. Cianchetti S, Bacci E, Ruocco L et al. Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects. Eur Respir J 2004 24 : 1018 24.
12. Noguera A, Batle S, Miralles C et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax 2001 56 : 432 7.
13. Fabbri LM, Romagnoli M, Corbetta L et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003 167 : 418 24.
14. Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley lecture. Chest 2000 117 : 251S 60S.
15. Culpitt SV, Rogers DF, Travers SL, Barnes PJ, Donnelly LE. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005 99 : 703 10.
16. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997 155 : 449 53.
17. Jones HA, Marino PS, Shakur BH, Morrell NW. In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J 2003 21 : 567 73.
18. Hoshi H, Ohno I, Honma M et al. Il-5, IL-8 and GM-CSF immunostaining of sputum cells in bronchial asthma and chronic bronchitis. Clin Exp Allergy 1995 25 : 720 8.
19. Tedeschi A, Arquati M, Lorini M, Miadonna A. Differential effect of hypertonicity on FMLP-, anti-IgE- and CA2+ ionophore A23187-induced histamine release from human basophil leukocytes. Int Arch Allergy Appl Immunol 1990 93 : 359 64.
20. Shapiro L, Dinarello CA. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res 1997 231 : 354 62.
21. Schroder AK, Uciechowski P, Fleischer D, Rink L. Crosslinking of CD66b on peripheral blood neutrophils mediates the release of interleukin-8 from intracellular storage. Hum Immunol 2006 67 : 676 82.
22. Oynebraten I, Barois N, Hagelsteen K, Johanseen FE, Bakke O, Haraldsen G. Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerol. J Immunol 2005 175 : 5358 69.
23. Celli BR, MacNee W, Committee Members. Standard for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004 23 : 932 46.
24. Paggiaro PL, Chanez P, Holz O et al. Sputum induction. Eur Respir J 2002 37 (Suppl.) : 3s 8s.
25. Bacci E, Cianchetti S, Carnevali S et al. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflammation 2002 11 : 293 8.
26. Chinn S. Repeatability and method comparison. Thorax 1991 46 : 454 6.
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986 i : 307 10.
28. Balzano G, Stefanelli F, Iorio C et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999 160 : 1486 92.
29. De Boer WI, Sont JK, van Schadewijk A, Stolk J, van Krieken JH, Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol 2000 190 : 619 26.
30. Fujimoto K, Yasuo M, Urushibata K, Hanaoka M, Koizumi T, Kubo K. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005 25 : 640 6.
31. Ciesla DJ, Moore EE, Biffl WL, Gonzalez RJ, Moore HB, Silliman CC. Hypertonic saline activation of p38 MAPK primes the PMN respiratory burst. Shock 2001 16 : 285 9.
32. Cuschieri J, Gourlay D, Garcia I, Jelacic S, Maier RV. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J Immunol 2002 168 : 1389 96.
33. Haslinger B, Mandl-Weber S, Sellmayer A, Lederer SR, Sitter T. Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: involvement of protein kinase C. Nephron 2001 87 : 346 51.
34. Loitsch SM, von Mallinckrodt C, Kippenberger S, Steinhilber D, Wagner TO, Bargon J. Reactive oxygen intermediates are involved in IL-8 production induced by hyperosmotic stress in human bronchial epithelial cells. Biochem Biophys Res Commun 2000 276 : 571 8.
35. Carpagnano GE, Foschino Barbaro MP, Cagnazzo M et al. Use of exhaled breath condensate in the study of airway inflammation after hypertonic saline solution challenge. Chest 2005 126 : 3159 66.
36. Taube C, Holz O, Mucke M, Jorres RA, Magnussen H. Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001 164 : 1810 5.
37. Brightling CE, Montero W, Green RH et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med 2001 95 : 999 1002.
38. Beeh KM, Beier J, Kornmann O, Mander A, Buhl R. Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. Chest 2003 123 : 778 83.
39. Kelly MG, Brown V, Martin L, Ennis M, Elborn JS. Comparison of sputum induction using high-output and low-output ultrasonic nebulizers in normal subjects and patients with COPD. Chest 2002 122 : 955 9.
40. Yumamoto C, Yoneda T, Yoshikawa M et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997 112 : 505 10.
41. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004 170 : 760 5.
42. Loppow D, Schleiss MB, Kanniess F, Taube C, Jorres RA, Magnussen H. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. Respir Med 2001 95 : 115 21.
43. Rytila PH, Lindqvist AE, Laitinen LA. Safety of sputum induction in chronic obstructive pulmonary disease. Eur Respir J 2000 15 : 1116 9.
44. Sutherland ER, Pak J, Langmack EL, Silkoff PE, Martin RJ. Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease. Respir Med 2002 96 : 482 6.